Pfizer plans to seek emergency use authorization from the Food and Drug Administration (FDA) for its COVID-19 vaccine for children ages 2 to 11, the company’s CEO said during a conference call Tuesday.
Children ages 2 to 11 could potentially be eligible for a Chinese Communist Party (CCP) Virus (COVID-19) vaccine this fall. That was reported by Pfizer President and CEO Albert Bourla, who said he expects to apply for emergency use authorization (EUA) from the FDA in September. According to his plan, a EUA application for ages six months to two years would follow in the fourth quarter.
In parallel, Pfizer and its partner BioNTech are currently awaiting a decision from the FDA on a EUA that would enable the application of their vaccine in adolescents aged 12 to 15 years.
The New York Times reported that approval could come late this week or early next week, giving teens a chance to get vaccinated before school starts in the fall.
President Biden said Tuesday that if approved by the FDA, officials will focus on making the vaccines available through pediatricians and family physicians. The president is challenging states to vaccinate as many adolescents as possible by July 4.
“Parents and their children can talk to their family doctor about it and get the vaccine from a provider they trust the most. Easy, fast and free,” Biden said. “And if teens are on the move this summer, they can get their first shot in one place and their second shot in another.”
These announcements are highly controversial, mainly because the vaccine in both adults and adolescents is still being tested.
Secondly, and no less critical, statistics show that both children and adolescents have extremely low rates of virus transmissibility, as demonstrated by the opening of schools worldwide. It was verified that even though students share several hours a day in small spaces, no significant sources of contagion were detected.
And in cases where children and adolescents are infected, mortality rates are insignificant.
Considering this data, the inevitable question arises: Why expose children to an experimentation process if they are not a significant part of the CCP Virus problem?
The credibility of CCP Virus vaccines and specifically the Pfizer vaccine in the United States is at a critical point due to a large number of reports of adverse effects and deaths following its use.
Recently, a Pfizer pharmaceutical company document published by alternative media further tarnished its image and helped to promote distrust for its effectiveness and adverse effects.
According to the Pfizer document it establishes a safety protocol for the trial period of the vaccine against the CCP Virus. One of its statements indicates that vaccinated persons could cause ‘serious adverse events’ to unvaccinated persons simply by breathing near or touching them.
The lengthy 146-page document was designed as a “study to evaluate the safety, tolerability, immunogenicity and efficacy of COVID-19 (CCP Virus) RNA vaccines in healthy persons,” is dated Nov. 2020.